Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001053369-16-000042

former Chairman sold 909,878 shares at an average $0.33 ($301,266)

  • former Chairman acquired 124,646 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TREPPEL JERRY · former Chairman

Table I: Non-derivative

8 lines
Date Transaction Shares Price Value Owned after D/I
2016-01-29 Sale : show line 1 in the form −115,000 $0.35 $40,250 9,081,769 D
2016-02-01 Sale : show line 2 in the form −312,300 $0.34 $106,182 8,769,469 D
2016-02-02 Sale : show line 3 in the form −13,000 $0.33 $4,290 8,756,469 D
2016-02-03 Sale : show line 4 in the form −45,518 $0.33 $15,021 8,710,951 D
2016-02-04 Sale : show line 5 in the form −349,660 $0.32 $111,891 8,361,291 D
2016-02-05 Sale : show line 6 in the form −24,400 $0.33 $8,052 8,336,891 D
2016-02-16 Grant or award : show line 7 in the form +124,646 $0.25 $30,900 8,461,537 D
2016-02-17 Sale : show line 8 in the form −50,000 $0.31 $15,580 8,411,537 D
Open-market sales · 909,878 sh · avg $0.33 · $301,266
Loading xslF345X03/primary_doc.xml…